A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Conditions
Breast Cancer · Small Cell Lung Cancer · Ovarian Cancer · Gastric Cancer · Hormone-receptor-positive Breast Cancer · Hormone Receptor Positive HER-2 Negative Breast Cancer · Advanced Solid Tumor · Endometrial Cancer · Prostate Cancer · TNBC - Triple-Negative Breast Cancer · GastroEsophageal Cancer · Bladder Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hoag Memorial Presbyterian, Newport Beach, California, United States
Florida Cancer Specialists and Research Institute, Lake Mary, Florida, United States
Washington University School of Medicine, St Louis, Missouri, United States
Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick, New Jersey, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
Mary Crowley Cancer Research, Dallas, Texas, United States
Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, Australia
Saint Vincents Hospital Sydney, Darlinghurst, New South Wales, Australia
Nepean Hospital, Kingswood, New South Wales, Australia
Genesiscare North Shore, St Leonards, New South Wales, Australia
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
Cancer Research South Australia, Adelaide, South Australia, Australia
Monash Health, Clayton, Victoria, Australia
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Beijing Cancer Hospital, Beijing, Beijing Municipality, China
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Hunan Cancer Hospital, Changsha, Hunan, China
Shengjing Hospital of China Medical Universityhuaxiang Branch, Shenyang, Liaoning, China
The First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi, China
Rambam Health Care Center, Haifa, Israel
Shaare Zedek Medical Center, Jerusalem, Israel
Auckland City Hospital, Auckland, New Zealand
Study leads
Study Director
BeiGene